Myocardial infarction: FDA reporting patterns
173,485 FDA FAERS reports mention Myocardial infarction. 172,033 reports have a serious outcome flag.
Medicines named as suspect
- Rosiglitazone: 34,545 reports
- Rofecoxib: 17,701 reports
- Celecoxib: 5,966 reports
- Metformin: 5,447 reports
- Sodium Chloride: 4,374 reports
- Adalimumab: 4,313 reports
- Calcium Chloride: 4,277 reports
- Magnesium Chloride: 4,248 reports
- Sodium Lactate: 4,238 reports
- Valsartan: 4,189 reports
- Dextrose: 4,050 reports
- Testosterone: 3,874 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.